ACAN and atrial fibrillation: The percentage of immunopositive cells surrounded by aggrecanase cleavage aggrecan products significantly increased at 7 and 28 days (P < 0.05) but significantly decreased at 56 days (P < 0.05) in the NP and AF (Figure 5b).